275
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Analysis of clinicopathological and cytogenetic differences between B-lymphoblastic lymphoma and B-lymphoblastic leukemia in childhood

, , &
Pages 2129-2135 | Received 18 Mar 2020, Accepted 21 Apr 2020, Published online: 19 May 2020

References

  • Borowitz MJ, Chan JKC, Downing JR, et al. B-lymphoblastic leukaemia/lymphoma, not otherwise specified (NOS). In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Revised. 4th ed. Lyon, France: IARC; 2017. p. 200–202.
  • Raetz EA, Perkins SL, Bhojwani D, et al. Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. Pediatr Blood Cancer. 2006;47(2):130–140.
  • Hoelzer D, Gökbuget N. T-cell lymphoblastic lymphoma and T-cell acute lymphoblastic leukemia: a separate entity? Clin Lymphoma Myeloma. 2009; 9(Suppl 3):S214–S221.
  • Meyer JA, Zhou D, Mason CC, et al. Genomic characterization of pediatric B-lymphoblastic lymphoma and B-lymphoblastic leukemia using formalin-fixed tissues. Pediatr Blood Cancer. 2017;64(7):e26363.
  • Burkhardt B. Paediatric lymphoblastic T-cell leukemia and lymphoma: one or two diseases? Br J Haematol. 2009;149(5):653–668.
  • Uyttebroeck A, van Hentenrijk V, Hagemeijer A, et al. Is there difference in childhood T-cell acute lymphoblastic leukaemia and T-cell lymphoblastic lymphoma? Leuk Lymphoma. 2007;48(9):1745–1754.
  • Burkhardt B, Moericke A, Klapper W, et al. Pediatric precursor T lymphoblastic leukemia and lymphoblastic lymphoma: differences in the common regions with loss of heterozygosity at chromosome 6q and their prognostic impact. Leuk Lymphoma. 2008;49(3):451–461.
  • Schraders M, van Reijmersdal SV, Kamping E, et al. High-resolution genomic profiling of pediatric lymphoblastic lymphomas reveals subtle differences with pediatric acute lymphoblastic leukemia in the B-lineage. Cancer Genet Cytogenet. 2009;191(1):27–33.
  • Borowitz MJ, Chan JKC, Downing JR, et al. B-lymphoblastic leukaemia/lymphoma with recurrent genetic abnormalities. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Revised. 4th ed. Lyon, France: IARC; 2017. p. 203–209.
  • Rahemtullah A, Reichard KK, Preffer FI, et al. A double-positive CD4 + CD8+ T-cell population is commonly found in nodular lymphocyte predominant Hodgkin lymphoma. Am J Clin Pathol. 2006;126(5):805–814.
  • Bain BJ, Barnett D, Linch D, et al. Revised guideline on immunophenotyping in acute leukaemias and chronic lymphoproliferative disorders. Clin Lab Haematol. 2002;24(1):1–13.
  • Reichard KK, Kang H, Robinett S. Pediatric B-lymphoblastic leukemia with RUNX1 amplification: clinicopathologic study of eight cases. Mod Pathol. 2011;24(12):1606–1611.
  • Leith CP, Carey J. Flow cytometric analysis of acute leukaemia. In: Keren DF, McCoy JP Jr, Carey JL, editors. Flow cytometry in clinical diagnosis. 3rd ed. Chicago, IL: ASCP Press; 2001. p. 339–378.
  • AALL0932: Treatment of patients with newly diagnosed standard risk B-lymphoblastic leukemia or localized B-lineage lymphoblastic lymphoma. Children’s Oncology Group website. [cited 2020 Mar 11]. https://www.childrensoncologygroup.org/aall0932.
  • Göhring G, Michalova K, Beverloo HB, et al. Complex karyotype newly defined: the strongest prognostic factor in advanced childhood myelodysplastic syndrome. Blood. 2010;116(19):3766–3769.
  • Maitra A, McKenna RW, Weinberg AG, et al. Precursor B-cell lymphoblastic lymphoma. Am J Clin Pathol. 2001;115(6):868–875.
  • Kang H, Wilson CS, Harvey RC, et al. Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children’s Oncology Group study. Blood. 2012;119(8):1872–1881.
  • Knez V, Liu X, Schowinsky J, et al. Clinical pathologic and genetic spectrum of infantile B-lymphoblastic leukemia: a multi-institutional study. Leuk Lymphoma. 2019;60(4):1006–1013.
  • Höpken UE, Rehm A. Targeting the tumor microenvironment of leukemia and lymphoma. Trends Cancer. 2019;5(6):351–364.
  • Sharma A, Boise LH, Shanmugam M. Cancer metabolism and the evasion of apoptotic cell death. Cancers (Basel. 2019;11(8):1144.
  • Lin P, Jones D, Dorfman DM, et al. Precursor B-cell lymphoblastic lymphoma: a predominantly extranodal tumor with low propensity for leukemic involvement. Am J Surg Pathol. 2000;24(11):1480–1490.
  • Möricke A, Zimmermann M, Valsecchi MG, et al. Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000. Blood. 2016;127(17):2101–2112.
  • Vora A, Goulden N, Wade R, et al. Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial. Lancet Oncol. 2013;14(3):199–209.
  • Place AE, Stevenson KE, Vrooman LM, et al. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial. Lancet Oncol. 2015;16(16):1677–1690.
  • Pieters R, de Groot-Kruseman H, Van der Velden V, et al. Successful therapy reduction and intensification for childhood acute lymphoblastic leukemia based on minimal residual disease monitoring: study ALL10 from the Dutch Childhood Oncology Group. JCO. 2016;34(22):2591–2601.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.